Keros Therapeutics Inc (KROS)
57.54
+1.23
(+2.18%)
USD |
NASDAQ |
May 01, 11:21
Keros Therapeutics Total Assets (Quarterly): 370.02M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 370.02M |
| September 30, 2023 | 326.25M |
| June 30, 2023 | 356.31M |
| March 31, 2023 | 384.44M |
| December 31, 2022 | 306.78M |
| September 30, 2022 | 252.55M |
| June 30, 2022 | 226.66M |
| March 31, 2022 | 235.14M |
| December 31, 2021 | 255.25M |
| Date | Value |
|---|---|
| September 30, 2021 | 229.96M |
| June 30, 2021 | 243.46M |
| March 31, 2021 | 257.73M |
| December 31, 2020 | 269.44M |
| September 30, 2020 | 138.25M |
| June 30, 2020 | 150.44M |
| March 31, 2020 | 60.59M |
| December 31, 2019 | 10.96M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
10.96M
Minimum
Dec 2019
384.44M
Maximum
Mar 2023
239.66M
Average
252.55M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 33.08B |
| Scholar Rock Holding Corp | 311.04M |
| Morphic Holding Inc | 682.76M |
| NovaBay Pharmaceuticals Inc | 9.034M |
| Palatin Technologies Inc | 13.55M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 37.81M |
| Shareholders Equity (Quarterly) | 332.21M |
| Current Ratio | 14.25 |